American Glaucoma Society Meeting

NASHVILLE, Tenn. — Patients who underwent MIGS procedures with and without phacoemulsification experienced IOP reductions and low complication rates, according to data from the IRIS Registry.

NASHVILLE, Tenn. — Patients with glaucoma who underwent trabeculectomy or tube shunt surgery had similar rates of reoperation and similar surgical outcomes regardless of initial procedure, according to a study.

NASHVILLE, Tenn. — It is important to use all of the tools available to diagnose glaucoma progression, according to a presentation at the American Glaucoma Society meeting.

NASHVILLE, Tenn. — When treating a patient with glaucoma, surgeons should take steps to anticipate and avoid problems related to unwanted blood, according to an expert.

NASHVILLE, Tenn. — At the American Glaucoma Society meeting, Osamah Saeedi, MD, discusses results from a study exploring the effect of Rhopressa (netarsudil ophthalmic solution 0.02%, Aerie Pharmaceuticals) on episcleral venous flow rates.

NASHVILLE, Tenn. — Stand-alone microstent implantation and trabeculectomy are both effective at treating glaucoma, with the microstent possibly providing an alternative to trabeculectomy, according to a study presented here.

NASHVILLE, Tenn. — At the American Glaucoma Society meeting, Arsham Sheybani, MD, discusses results from the Gold Standard Pathway Study, which evaluated the effectiveness and safety of the Xen gel stent (Allergan) vs. trabeculectomy.

NASHVILLE, Tenn. — Patients with open-angle glaucoma had favorable outcome 3 years after undergoing stand-alone SIBS microshunt implantation, according to a study.